TMEM65 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.032000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.988200E-01
Normal-vs-Stage2
9.751200E-01
Normal-vs-Stage3
4.620800E-01
Normal-vs-Stage4
8.208600E-01
Stage1-vs-Stage2
8.968400E-01
Stage1-vs-Stage3
1.686580E-01
Stage1-vs-Stage4
7.836800E-01
Stage2-vs-Stage3
4.750400E-01
Stage2-vs-Stage4
6.893000E-01
Stage3-vs-Stage4
4.907400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.995800E-01
Normal-vs-AfricanAmerican
7.931600E-01
Normal-vs-Asian
7.704800E-01
Caucasian-vs-AfricanAmerican
8.765200E-01
Caucasian-vs-Asian
5.204200E-01
AfricanAmerican-vs-Asian
4.608000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.350800E-01
Normal-vs-Female
8.556200E-01
Male-vs-Female
6.727000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.842200E-01
Normal-vs-Age(41-60Yrs)
4.879800E-01
Normal-vs-Age(61-80Yrs)
8.632000E-01
Normal-vs-Age(81-100Yrs)
3.786600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.783800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.747600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.191400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.995800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.602800E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.639600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.144000E-01
Normal-vs-Daily Drinker
5.740600E-01
Normal-vs-Weekly Drinker
9.341600E-01
Normal-vs-Occasional Drinker
4.197400E-01
Normal-vs-Social Drinker
8.887000E-01
Non Drinker-vs-Daily Drinker
6.334600E-01
Non Drinker-vs-Weekly Drinker
5.238400E-01
Non Drinker-vs-Occasional Drinker
3.146300E-02
Non Drinker-vs-Social Drinker
8.444600E-01
Daily Drinker-vs-Weekly Drinker
3.202400E-01
Daily Drinker-vs-Occasional Drinker
2.214000E-02
Daily Drinker-vs-Social Drinker
5.995400E-01
Weekly Drinker-vs-Occasional Drinker
1.084030E-01
Weekly Drinker-vs-Social Drinker
7.138000E-01
Occasional Drinker-vs-Social Drinker
5.978500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.334400E-01
Normal-vs-Grade 2
8.847800E-01
Normal-vs-Grade 3
8.874400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.970200E-01
Grade 1-vs-Grade 3
4.199200E-01
Grade 1-vs-Grade 4
9.334400E-01
Grade 2-vs-Grade 3
9.598400E-01
Grade 2-vs-Grade 4
8.847800E-01
Grade 3-vs-Grade 4
8.874400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.416800E-01
Normal-vs-NonDiabetic
9.230800E-01
Diabetic-vs-NonDiabetic
9.855400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.677200E-01
Normal-vs-NoPancreatitis
9.181600E-01
Pancreatitis-vs-NoPancreatitis
1.468220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.790400E-01
Normal-vs-N1
9.435800E-01
N0-vs-N1
7.069400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.079200E-01
Normal-vs-TP53-NonMutant
9.601800E-01
TP53-Mutant-vs-TP53-NonMutant
4.618000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
